Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1EPRATUZUMAB[1] Epratuzumab (Epratuzumab)[1] Epratuzumab (Epratuzumab) 💬 [1] CD22 💬 [3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬[1] 49 💬
2Epratuzumab 100 mg[1] Epratuzumab (Epratuzumab)[1] Epratuzumab (Epratuzumab) 💬 [1] CD22 💬 [3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬[1] 49 💬
3Epratuzumab 1200 mg[1] Epratuzumab (Epratuzumab)[1] Epratuzumab (Epratuzumab) 💬 [1] CD22 💬 [3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬[1] 49 💬
4Epratuzumab 400 mg[1] Epratuzumab (Epratuzumab)[1] Epratuzumab (Epratuzumab) 💬 [1] CD22 💬 [3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬[1] 49 💬
5Epratuzumab 600 mg[1] Epratuzumab (Epratuzumab)[1] Epratuzumab (Epratuzumab) 💬 [1] CD22 💬 [3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬[1] 49 💬
6Epratuzumab iv[1] Epratuzumab (Epratuzumab)[1] Epratuzumab (Epratuzumab) 💬 [1] CD22 💬 [3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬[1] 49 💬
7Epratuzumab sc[1] Epratuzumab (Epratuzumab)[1] Epratuzumab (Epratuzumab) 💬 [1] CD22 💬 [3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬[1] 49 💬
8HLL2 (Epratuzumab)[1] Epratuzumab (Epratuzumab)[1] Epratuzumab (Epratuzumab) 💬 [1] CD22 💬 [3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬[1] 49 💬